Resumen:

PROHIBESE EL USO Y LA COMERCIALIZACION EN TODO EL TERRITORIO NACIONAL DE TODOS LOS LOTES DE LOS PRODUCTOS ROTULADOS COMO: “MISOPROSTOL TABLETS 200 MCG. PSHSI KHUSHI MISO. MANUFACTURED IN INDIA BY ACCENT PHARMACEUTICALS & DIAGNOSTICS. MARKETED BY POPULATION HEALTH SERVICE (INDIA)”; MIFEPRISTONE TABLETS 200 MG. PSHSI KHUSHI MIFE. MANUFACTURED IN INDIA BY ACCENT PHARMACEUTICALS & DIAGNOSTICS. MARKETED BY POPULATION HEALTH SERVICE (INDIA)”; Y CYTOTEC 200 MICROGRAM TABLETS, MISOPROSTOL 60 TABLETS. PHARMACIA”; EN VIRTUD DE LOS ARGUMENTOS EXPUESTOS EN EL CONSIDERANDO DE LA PRESENTE.